Aspen Wealth Strategies LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Aspen Wealth Strategies LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,750 shares of the healthcare conglomerate’s stock after selling 126 shares during the period. UnitedHealth Group comprises approximately 0.7% of Aspen Wealth Strategies LLC’s investment portfolio, making the stock its 21st biggest position. Aspen Wealth Strategies LLC’s holdings in UnitedHealth Group were worth $1,023,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth about $27,000. Global Wealth Strategies & Associates raised its position in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares in the last quarter. Macroview Investment Management LLC boosted its position in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares in the last quarter. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $32,000. Finally, Delos Wealth Advisors LLC boosted its stake in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after acquiring an additional 53 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of research analyst reports. Argus increased their price target on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Cantor Fitzgerald raised their target price on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Robert W. Baird raised their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Up 0.3 %

UnitedHealth Group stock opened at $564.40 on Friday. The stock has a market capitalization of $521.18 billion, a PE ratio of 36.77, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. The business has a 50 day simple moving average of $582.30 and a 200-day simple moving average of $540.65. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period in the previous year, the business earned $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.